(Q42528452)

1 November 2017

title

Telomerase reverse transcriptase subunit immunoreactivity: a marker for high-grade prostate carcinoma (English)

1 reference

1 November 2017

1

Kenneth A Iczkowski

1 reference

1 November 2017

Cooley G Pantazis

2

1 reference

1 November 2017

Douglas H McGregor

series ordinal

3

1 reference

1 November 2017

Yaping Wu

series ordinal

4

1 reference

1 November 2017

Ossama W Tawfik

series ordinal

5

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

1 November 2017

1 reference

1 November 2017

volume

95

1 reference

1 November 2017

issue

12

1 reference

1 November 2017

page(s)

2487-2493

1 reference

Telomerase activity in primary prostate cancer

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10988

7 January 2021

Detection of telomerase activity in human prostate: a diagnostic marker for prostatic cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10988

7 January 2021

Detection of telomerase activity in prostate needle-biopsy samples

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10988

7 January 2021

Telomerase activity, telomere length, and DNA ploidy in prostatic intraepithelial neoplasia (PIN)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10988

7 January 2021

Focal intratumoral heterogeneity for telomerase activity in human prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10988

7 January 2021

Telomerase activity in prostate sextant needle cores from radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10988

7 January 2021

Expression of the RNA component of human telomerase (hTR) in prostate cancer, prostatic intraepithelial neoplasia, and normal prostate tissue

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10988

7 January 2021

Gleason score 7 prostate cancer: a heterogeneous entity? Correlation with pathologic parameters and disease-free survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10988

7 January 2021

Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10988

7 January 2021

Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10988

7 January 2021

Localization of telomerase hTERT protein and hTR in benign mucosa, dysplasia, and squamous cell carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10988

7 January 2021

The use of telomerase activity for the detection of prostatic cancer cells after prostatic massage

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10988

7 January 2021

Detection of telomerase activity in prostatic fluid specimens

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10988

7 January 2021

Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10988

7 January 2021

The RNA component of human telomerase

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10988

7 January 2021

An appraisal of telomerase activity in benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10988

7 January 2021

Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10988

7 January 2021

Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10988

7 January 2021

Expression of telomerase reverse transcriptase (TERT) in malignant mesotheliomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10988

7 January 2021

Monoclonal antibodies against human telomerase reverse transcriptase (hTERT): preparation, characterization, and application

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10988

7 January 2021

P504S: a new molecular marker for the detection of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10988

7 January 2021

Identifiers

DOI

10.1002/CNCR.10988

1 reference

1 November 2017

1 reference